Irisin and Visfatin Predicts Severity of Diabetic Nephropathy

• Published in: Indian journal of clinical biochemistry Vol. 34; no. 3; pp. 342 - 346
• Main Authors: Mageswari, Ramalingam, Sridhar, M. G., Nandeesha, H., Parameshwaran, Sreejith, Vinod, K. V.
• Format: Journal Article
• Language: English
• Published: New Delhi Springer India 01.07.2019; Springer; Springer Nature B.V
• Subjects: Albumin; Biochemistry; Biomedical and Life Sciences; Chemistry/Food Science; Comparative analysis; Creatinine; Diabetes; Diabetes mellitus; Diabetic nephropathies; Diabetic nephropathy; Diabetic neuropathy; Epidermal growth factor receptors; Glucose; Life Sciences; Microbiology; Nephropathy; Original; Original Research Article; Pathology; Serum levels; Type 2 diabetes; Urine; Irisin; Nephropathy; Visfatin; Diabetes mellitus; Adiponectin
• ISSN: 0970-1915; 0974-0422
• DOI: 10.1007/s12291-018-0749-7

Although the roles of irisin and visfatin have been well established in diabetes mellitus, there are limited studies about their association in diabetic nephropathy. The present study was designed to assess the levels of irisin and visfatin and their association with the severity of diabetic nephropathy. 43 diabetic nephropathy cases and 43 diabetic subjects without nephropathy were enrolled in the study. Serum levels of irisin and visfatin were compared in both the groups. Irisin and visfatin were significantly increased in diabetic nephropathy cases when compared with diabetes subjects without nephropathy. eGFR was negatively correlated with visfatin (r = −0.323, p  = 0.034), irisin (r = −0.324, p  = 0.034), urine albumin (r = −0.443, p  = 0.003) and albumin creatinine ratio (r = −0.419, p  = 0.005) in patients with diabetic nephropathy. Visfatin was significantly elevated in stage IV nephropathy compared with stage III nephropathy. We conclude that irisin and visfatin are elevated in diabetic nephropathy and can be an index of its severity.